Runs aplenty: New Zealand declares at 575 and West Indies 110-0 after Day 2 of the 3rd test
MOUNT MAUNGANUI, New Zealand (AP) — Devon Conway scored his second test double century more than four years…
Contract awarded to manufacture WA’s first electric ferry fleet
WA-based shipbuilder Echo Marine Group to design and construct five new electric ferries for the METRONET on Swan…
Want $10,000 in Passive Income? This Vanguard ETF Could Be Your Ticket to Making It Happen.
Investors would need to have over $330,000 invested in this Vanguard dividend ETF. The beauty of passive income…
Down More About 45% From Recent Highs, Is Now the Time to Buy Oracle Stock?
Oracle stock’s recent sell-off reflects growing unease about the cost and timing of its AI infrastructure gamble. If…
Billionaire Bill Gates Has 60% of His Foundation’s $37 Billion Portfolio Invested in Noticeably Non-Tech Stocks Heading Into 2026
Gates is more interested in stalwart, boring businesses than high-flying tech. Bill Gates built his fortune through Microsoft,…
Can the Stock Market Keep Climbing in 2026? Ignoring This Trend Could Cost Investors Dearly.
Stocks look expensive and AI-bubble fears abound, but here’s what history says. Investors are having another banner year…
Financial Services Bulletin December 2025: Allen & Gledhill
19 December 2025
We are pleased to…
Honouring the victims of the Bondi Beach terrorist attack
The Commonwealth and State government will also work closely with the Jewish community on arrangements for a National…
Russia sues Euroclear as EU debates frozen assets for Ukraine – news.cgtn.com
Russia sues Euroclear as EU debates frozen assets for Ukraine news.cgtn.comEU agree €90bn loan for Ukraine but without using…
Why AI Stock HeartFlow Triumphed on Thursday
A key FDA-cleared analysis tool earned professional accolades for its utility. HeartFlow (HTFL +8.98%) had a Thursday to…
What to Know About the Deal Giving American Investors a Big Stake in TikTok
Key Takeaways TikTok agreed to a new joint venture that will be controlled by American investors, according to…
Is It Too Late To Consider AstraZeneca After Its Strong 2025 Share Price Rally?
For anyone wondering whether AstraZeneca is still worth considering after its big run or whether the best days…